References
- Akmaev IG. Neuroimmunoendocrinology: sources and prospects of development. Succ Physiol Sci. 2003;34/4:4–15.
- Ashmarin IP, Koroleva SV. Regularities of interaction and functional continuum of neuropeptides (on the way to a unified concept): Overview. Bull Rus Acad Med Sci..2002;6:40–48.
- Ashmarin I.P., Nezavibatko V.N., Myasoedov N.F., Kamensky A.A., Grivennikov I.A., Ponomareva-Stepnaya M.A. et al. Nootropic analogue of adrenocorticotropin 4-10-semax (the experience of design and investigation over 15 years). Journal of Higher Nervous Activity. I. Pavlova. 1997; 47(2): 429–430.
- Ashmarin IP, Obukhova MF. The current state of the hypothesis of a functional continuum of regulatory peptides. Vestnik RAMN. 1994;10:28–34.
- Belokrylov GA, Malchanova IV. Levamin and cerebrolysin as immunostimulants. Biull Eksp Biol Med. 1992;113(2):165–6.
- Bulgakova OS. Immunity and various stages of stress effects. Succ Mod Nat Sci. 2011;4:31–35.
- Dolotov OV, Eremin KO, Andreeva LA et al. Semax prevents the death of tyrosine hydroxylase-positive neurons in a mixed neuroglial cell culture derived from the embryonic rat mesencephalon in a model of 6-hydroxydopamine-induced neurotoxicity.. Neurochemistry. 2015;32/4:317–321.
- Eremin K.O., Kudrin V.S., Rayevsky K.S., Saransaari P., Oja S.S., Grivennikov I.A., Myasoedov N.F. Semax, an ACTH(4–10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents. Neurochemical Research. 2005; 30(12): 1493–1500.
- Gabbyasova Yu.R., Tret’yakov D.A., Pleten’ A.P. Peptides of the brain (review). New science: current state and development paths. 2017; 3/3:36–41.
- Garmanchuk LV, Perepelitsyna EM, Sidorenko Mv, Makarenko AN, Kul’chikov AE. Cytoprotective effect of neuropeptides on immunocompetent cells (in vitro study). Eksperimental clinical pharmakology. 2009; Jul–Aug;72(4):28–32.
- Gromov L.A. Neuropeptides. Kiev: Zdorov’e; 1992; 245.
- Kolomin T.A., Agapova T. Yu., Agnilullin Ya. V., Shram S.I., Shadrina M.I., Slominskiy P.A. i dr. Change in the transcriptome profile of the hippocampus in response to the introduction of the analog of taftcin selank. Journal of Higher Nervous Activity. I. Pavlova.2013; 63(3): 365–374.
- Kudryavtseva NN. Serotonergic control of aggressive behavior: new approaches - new interpretations (review). J High Nerv Act.(I.P. Pavlova). 2015:65/5:546.
- Levitskaya N.G., Glazova N.Yu., Sebentsova E.A., Manchenko D.M., Vilenskiy D.A., Andreeva L.A. Investigation of the spectrum of physiological activity of analogue ACTG4-10 heptapeptide semax. Neurochemistry. 2008; 25(1): 111–118.
- Mironov AN, ed. A guide to preclinical drug research. Part One. Moscow, Grief and K; 2012: 944
- Perel’muter V.M., Odintsov Yu. N., Kliment’eva T.K. Taftsin is a natural immunomodulator. Possible role in tumor progression. Siberian Journal of Oncology. 2004; 12(4): C. 57–62.
- Titov VN. Biological function of stress, congenital immunity, inflammation reaction and arterial hypertension. Clin Lab Diagn. 2008;12:3–16.
- Fedorova OV, Krayushkina NG, Shefer EG. Poststressing modulation of immunogenesis organs. Bull Volg State Med Univ. 2010;3/35:8–12.
- Khavinson VKh, Kvetnoy IM, Ashmarin IP. Peptidergic regulation of homeostasis. Succ Mod Biol. 2002;122:190–203.
- Khnychenko LK, Sapronov NS. Stress and its role in the development of pathological processes. Rev Clin Pharm Drug Ther. 2003; 2/3:2–15.
- Sever’yanova L.A., Bobyntsev I.I., Kryukov A.A. Neuropeptides and active amino acids: effects on various types of pain sensitivity and pain-induced behavior. Patogenez. 2005; 3(1): 23–24.
- Skrebitskiy VG, Kasyan AP, Povarov IS, Kondratenko RV, Slominskiy PA. Neuropeptide drug Selank: biological activity and fundamental mechanisms of action. Nerv Dis. 2016; 4:52–56.
- Uchakina O.N., Uchakin P.N., Myasoedov N.F., Andreeva L.A., Shcherbenko V.E., Mezentseva M.V. Immunomodulating properties of Selank in people with anxiety-asthenic disorders. Journal of Neurology and Psychiatry. S.S. Korsakov.2008; 5: 71–75.
- Volkova A., Shadrina M., Kolomin T., Andreeva L., Limborska S., Myasoedov N., Slominsky P. Selank administration affects the expression of some genes involved in gabaergic neurotransmission. Frontiers in Pharmacology. 2016; 7: 31.
- Deak T, Quinn M, Cidlowski JA, Victoria NC, Murphy AZ, Sheridan JF. Neuroimmune mechanisms of stress: sex differences, developmental plasticity, and implications for stress-related disease. Stress 2015;18(4):367–380.
- Formichi P, Radi E, Battisti C, Di Maio G, Muresanu D, Federico A. Cerebrolysin administration reduces oxidative stress-induced apoptosis in lymphocytes from healthy individuals. J Cell Mol Med. 2012;16(11):2840–2843.
- Hallberg M. Neuropeptides: metabolism to bioactive fragments and the pharmacology of their receptors. Med Res Rev. 2015;35(3):464–519
- Semmens DC, Elphick MR. The evolution of neuropeptide signalling: insights from echinoderms. Brief Funct Genomics. 2017;16(5):288–298.
- Yugan YL, Sotskaya YA, Chabarova AB. The effectiveness of the modern immunoactive preparation immunofan for medical rehabilitation of patients with nonalcoholic steatohepatitisis against neurocirculatory dystonia, after infectious mononucleosis. Lik Sprava. 2015; (5–6):132–139.